Roles of FHIT and WWOX fragile genes in cancer
- PMID: 16225988
- DOI: 10.1016/j.canlet.2005.06.048
Roles of FHIT and WWOX fragile genes in cancer
Abstract
It was hypothesized as early as 1986, that the recently discovered common fragile sites could facilitate recombination events, such as deletions and translocations, that result in clonally expanded cancer cell populations with specific chromosome alterations in specific cancer types. A natural extension of this hypothesis is that the clonal expansion must be driven by alteration of genes at recombination breakpoints whose altered functions actually drive clonal expansion. Nevertheless, when the FHIT gene was discovered at FRA3B, the most active common chromosome fragile region, and proposed as an example of a tumor suppressor gene altered by chromosome translocations and deletions, a wave of reports suggested that the FHIT gene was altered in cancer simply because it was in a fragile region and not because it had contributed to the clonal expansion, thus turning the original hypothesis upside down. Now, after nearly ten years and more than 500 FHIT reports, it is apparent that FHIT is an important tumor suppressor gene and that there are genes at other fragile regions that contribute significantly to development of cancer. A second fragile gene with a demonstrated role in cancer development is the WWOX gene on chromosome 16q; alterations to the WWOX gene contribute to development of hormone responsive and other cancers. Results of our recent studies of these two fragile tumor suppressor genes were summarized at the first Fragilome meeting in Heidelberg, Feb. 2005.
Similar articles
-
Large common fragile site genes and cancer.Semin Cancer Biol. 2007 Feb;17(1):31-41. doi: 10.1016/j.semcancer.2006.10.003. Epub 2006 Oct 26. Semin Cancer Biol. 2007. PMID: 17140807 Review.
-
A novel approach to simultaneously scan genes at fragile sites.BMC Cancer. 2006 Aug 8;6:205. doi: 10.1186/1471-2407-6-205. BMC Cancer. 2006. PMID: 16895604 Free PMC article.
-
Common chromosomal fragile sites and cancer: focus on FRA16D.Cancer Lett. 2006 Jan 28;232(1):37-47. doi: 10.1016/j.canlet.2005.07.041. Epub 2005 Oct 20. Cancer Lett. 2006. PMID: 16242840 Review.
-
Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.Mol Cancer Res. 2003 Nov;1(13):940-7. Mol Cancer Res. 2003. PMID: 14638866
-
Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.Genes Chromosomes Cancer. 2001 Mar;30(3):292-8. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1095>3.0.co;2-f. Genes Chromosomes Cancer. 2001. PMID: 11170287
Cited by
-
A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer.NAR Genom Bioinform. 2024 May 25;6(2):lqae057. doi: 10.1093/nargab/lqae057. eCollection 2024 Jun. NAR Genom Bioinform. 2024. PMID: 38800828 Free PMC article.
-
Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.Int J Mol Sci. 2024 Mar 20;25(6):3507. doi: 10.3390/ijms25063507. Int J Mol Sci. 2024. PMID: 38542478 Free PMC article. Review.
-
Fragile sites, chromosomal lesions, tandem repeats, and disease.Front Genet. 2022 Nov 17;13:985975. doi: 10.3389/fgene.2022.985975. eCollection 2022. Front Genet. 2022. PMID: 36468036 Free PMC article. Review.
-
Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia.J Lipid Res. 2022 Jun;63(6):100209. doi: 10.1016/j.jlr.2022.100209. Epub 2022 Apr 20. J Lipid Res. 2022. PMID: 35460704 Free PMC article.
-
The oncological relevance of fragile sites in cancer.Commun Biol. 2021 May 12;4(1):567. doi: 10.1038/s42003-021-02020-5. Commun Biol. 2021. PMID: 33980983 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources